Lista de obras - Pierre-Jean Lamy - Dominio Público Uruguay

Added value of hepcidin quantification for the diagnosis and follow-up of anemia-related diseases.

artículo científico publicado en 2017

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.

artículo científico publicado en 2015

Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancer

artículo científico publicado en 2001

Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data

scientific article published on 02 June 2020

Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification

artículo científico publicado en 2013

Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes

scientific article published in Scientific Reports

BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer

artículo científico publicado en 2013

Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment.

artículo científico publicado en 2013

Circadian genes and risk of prostate cancer: Findings from the EPICAP study

scientific article published on 12 February 2019

Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.

artículo científico publicado en 2013

Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer

scientific article published on 01 October 2008

Clinical utility of serum human epidermal growth factor receptor 2 extracellular domain levels: stop the shilly-shally--it is time for a well-designed, large-scale prospective study.

artículo científico publicado en 2009

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

artículo científico publicado en 2014

Development of digital PCR molecular tests for clinical practice: principles, practical implementation and recommendations

scientific article published on 01 October 2018

Development of molecular analysis by digital PCR for clinical practice: positioning, current applications and perspectives

scientific article published on 01 December 2019

Diagnosis, and prognosis of AIDS-related cholangitis ⬇️

artículo científico publicado el 1 de agosto de 1995

Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers

artículo científico publicado en 2007

Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France

artículo científico publicado en 2014

Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer

artículo científico publicado en 2013

Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP study.

artículo científico publicado en 2018

HER2 shedding and serum HER2 extracellular domain: biology and clinical utility in breast cancer.

scientific article published on 05 May 2011

High fasting serum insulin level due to autoantibody interference in insulin immunoassay discloses autoimmune insulin syndrome: a case report

artículo científico publicado en 2016

Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.

artículo científico publicado en 2009

Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study

artículo científico publicado en 2016

Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study.

artículo científico publicado en 2018

Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy

artículo científico publicado en 2012

Iron homeostasis and anemia markers in early breast cancer

artículo científico publicado en 2014

KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues ⬇️

artículo científico

KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?

artículo científico publicado en 2010

Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study

scientific article published on 16 October 2020

Measles virus exploits dendritic cells to suppress CD4+ T-cell proliferation via expression of surface viral glycoproteins independently of T-cell trans-infection

artículo científico publicado en 2001

NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer

artículo científico publicado en 2006

Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer

artículo científico publicado en 2003

Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.

artículo científico publicado en 2015

Night work and prostate cancer risk: results from the EPICAP Study

artículo científico publicado en 2018

Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study.

artículo científico publicado en 2017

PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy

artículo científico publicado en 2019

Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer

scientific article published on 01 September 2000

Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapy

artículo científico publicado en 2002

Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review

artículo científico publicado en 2017

Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancer

artículo científico publicado en 2014

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

artículo científico publicado en 2018

Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers ⬇️

artículo científico publicado el 2 de febrero de 2011

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†.

artículo científico publicado en 2015

Rates of total and free PSA prescriptions in France (2012-2014)

artículo científico publicado en 2017

Re: clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review

artículo científico publicado en 2012

Relevance of total PSA and free PSA prescriptions

artículo científico publicado en 2018

Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer

artículo científico publicado en 2015

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients

artículo científico publicado en 2016

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.

artículo científico publicado en 2014

Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?

artículo científico publicado en 2016

Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer.

artículo científico publicado en 2017

Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer

artículo científico publicado en 2012

Serum protein signature may improve detection of ductal carcinoma in situ of the breast

artículo científico publicado en 2009

TOP2A amplification in breast cancer in the absence of that of HER-2: myth or reality?

artículo científico publicado en 2012

Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations?

artículo científico publicado en 2015

The HER2 amplicon in breast cancer: Topoisomerase IIA and beyond.

artículo científico

The level of evidence for the use of biomarkers in the early detection of prostate cancer

artículo científico publicado en 2016

Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expression

artículo científico publicado en 2007

Worldwide variations in EGFR somatic mutations: a challenge for personalized medicine

artículo científico publicado en 2012

[Early biological detection of prostate cancer: which test to use?]

artículo científico publicado en 2015

[HE4, a novel marker for epithelial ovarian cancer: evaluation of analytical performances]

scientific article published on 01 May 2010

[Iron metabolism in breast cancer: knowledge and future]

artículo científico publicado en 2012

[The PSA caught out]

artículo científico publicado en 2015

[UPA/PAI-1: a tool for breast cancer treatment individualization. Biology, clinical implications and quantification assays]

artículo científico publicado en 2010

[Vitamin D and breast cancer: physiopathology, biological and clinical implications].

artículo científico publicado en 2014

[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management]

artículo científico publicado en 2014

[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management].

artículo científico publicado en 2015

Lista de obras de Pierre-Jean Lamy

Added value of hepcidin quantification for the diagnosis and follow-up of anemia-related diseases.

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.

Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancer

Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data

Anemia and iron biomarkers in patients with early breast cancer. Diagnostic value of hepcidin and soluble transferrin receptor quantification

Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes

BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer

Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment.

Circadian genes and risk of prostate cancer: Findings from the EPICAP study

Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.

Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer

Clinical utility of serum human epidermal growth factor receptor 2 extracellular domain levels: stop the shilly-shally--it is time for a well-designed, large-scale prospective study.

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

Development of digital PCR molecular tests for clinical practice: principles, practical implementation and recommendations

Development of molecular analysis by digital PCR for clinical practice: positioning, current applications and perspectives

Diagnosis, and prognosis of AIDS-related cholangitis ⬇️

Docetaxel and cisplatin in patients with metastatic androgen independent prostate cancer and circulating neuroendocrine markers

Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France

Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer

Family history of breast cancer increases the risk of prostate cancer: results from the EPICAP study.

HER2 shedding and serum HER2 extracellular domain: biology and clinical utility in breast cancer.

High fasting serum insulin level due to autoantibody interference in insulin immunoassay discloses autoimmune insulin syndrome: a case report

Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.

Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study

Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study.

Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy

Iron homeostasis and anemia markers in early breast cancer

KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues ⬇️

KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?

Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study

Measles virus exploits dendritic cells to suppress CD4+ T-cell proliferation via expression of surface viral glycoproteins independently of T-cell trans-infection

NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer

Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer

Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.

Night work and prostate cancer risk: results from the EPICAP Study

Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study.

PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy

Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer

Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapy

Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review

Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancer

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers ⬇️

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†.

Rates of total and free PSA prescriptions in France (2012-2014)

Re: clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic review

Relevance of total PSA and free PSA prescriptions

Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.

Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?

Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer.

Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer

Serum protein signature may improve detection of ductal carcinoma in situ of the breast

TOP2A amplification in breast cancer in the absence of that of HER-2: myth or reality?

Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations?

The HER2 amplicon in breast cancer: Topoisomerase IIA and beyond.

The level of evidence for the use of biomarkers in the early detection of prostate cancer

Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expression

Worldwide variations in EGFR somatic mutations: a challenge for personalized medicine

[Early biological detection of prostate cancer: which test to use?]

[HE4, a novel marker for epithelial ovarian cancer: evaluation of analytical performances]

[Iron metabolism in breast cancer: knowledge and future]

[The PSA caught out]

[UPA/PAI-1: a tool for breast cancer treatment individualization. Biology, clinical implications and quantification assays]

[Vitamin D and breast cancer: physiopathology, biological and clinical implications].

[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management]

[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management].